For example, activation of cannabinoid receptor 2 (CB2) has been shown to attenuate d-Galactosamine (GalN)/lipopolysaccharide (LPS)-induced acute liver failure by inducing an M1 to M2 shift in macrophages (43). The gene discussed is CNR2; the disease is acute liver failure.